Given the clinical significance of CD4+ T cell deficiency to the susceptibility to cryptococcosis in patients, it is critical to know whether host protection can be established following HK-fbp1 vaccination in CD4+ T cell-deficient hosts. This evidence concerns the gene FBP1 and cryptococcosis.